Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 20 M37 M35 M48 M49 M 169 M Research & development ————— — Operating income 547 M568 M586 M630 M657 M 2.44 B Non-Operating Income, Total 10 M13 M8 M-19 M-8 M -6 M Interest expense, net of interest capitalized 96 M95 M87 M89 M87 M 358 M Non-Operating Income, excl. Interest Expenses -85 M-83 M-79 M-81 M-81 M -324 M Unusual income/expense -1 M1 M0-27 M-14 M -40 M Pretax income 488 M548 M529 M580 M677 M 2.33 B Equity in earnings 27 M23 M24 M9 M26 M 82 M Taxes 93 M96 M106 M63 M158 M 423 M Non-controlling/minority interest 000-1 M— — After tax other income/expense 11 M-2 M-8 M-22 M-21 M -53 M Net income before discontinued operations 395 M452 M423 M518 M519 M 1.91 B Discontinued operations ————88 M — Net income 395 M452 M423 M518 M519 M 1.91 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 395 M452 M423 M518 M519 M 1.91 B Basic earnings per share (Basic EPS) 0.690.790.740.90.92 3.35 Diluted earnings per share (Diluted EPS) 0.680.780.730.90.91 3.32 Average basic shares outstanding 575.05 M574.07 M573.29 M573.26 M566.82 M — Diluted shares outstanding 579.98 M578.98 M578.98 M578.6 M571.75 M — EBITDA 1.75 B1.72 B1.6 B2.12 B1.76 B 7.21 B EBIT 1.63 B1.6 B1.48 B1.63 B1.64 B 6.35 B Cost of revenue 853 M784 M643 M727 M730 M 2.88 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 125 M122 M122 M487 M121 M 852 M